blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP4406593

EP4406593 - USE OF LONG-ACTING GLP-1 PEPTIDES [Right-click to bookmark this link]
StatusThe application has been published
Status updated on  27.06.2024
Database last updated on 15.11.2024
Most recent event   Tooltip20.09.2024Publication of search reportpublished on 23.10.2024  [2024/43]
20.09.2024Change - classificationpublished on 23.10.2024  [2024/43]
20.09.2024Change - classificationpublished on 23.10.2024  [2024/43]
Applicant(s)For all designated states
Novo Nordisk A/S
Novo Allé 1
2880 Bagsvaerd / DK
[2024/31]
Inventor(s)01 / JENSEN, Christine Bjørn
2880 Bagsværd / DK
02 / RASMUSSEN, Mads Frederik
2880 Bagsværd / DK
03 / ZDRAVKOVIC, Milan
2880 Bagsværd / DK
04 / KRISTENSEN, Peter
2880 Bagsværd / DK
 [2024/31]
Application number, filing date24175788.921.06.2013
[2024/31]
Priority number, dateEP2012017453501.07.2012         Original published format: EP 12174535
US201261694837P30.08.2012         Original published format: US 201261694837 P
EP2012018678101.10.2012         Original published format: EP 12186781
US201261708162P01.10.2012         Original published format: US 201261708162 P
[2024/31]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP4406593
Date:31.07.2024
Language:EN
[2024/31]
Type: A3 Search report 
No.:EP4406593
Date:23.10.2024
Language:EN
[2024/43]
Search report(s)(Supplementary) European search report - dispatched on:EP25.09.2024
ClassificationIPC:A61K38/26, A61P3/04
[2024/43]
CPC:
A61K38/26 (EP,RU,US); A61P3/04 (EP,US)
C-Set:
A61K38/26, A61K2300/00 (EP)
Former IPC [2024/31]A61P3/04
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2024/31]
TitleGerman:VERWENDUNG VON GLP-1-PEPTIDEN MIT LANGZEITWIRKUNG[2024/31]
English:USE OF LONG-ACTING GLP-1 PEPTIDES[2024/31]
French:UTILISATION DE PEPTIDES GLP-1 A ACTION PROLONGEE[2024/31]
Parent application(s)   TooltipEP13737808.9  / EP2866825
EP20157813.5  / EP3689365
Fees paidRenewal fee
16.09.2024Renewal fee patent year 03
16.09.2024Renewal fee patent year 04
16.09.2024Renewal fee patent year 05
16.09.2024Renewal fee patent year 06
16.09.2024Renewal fee patent year 07
16.09.2024Renewal fee patent year 08
16.09.2024Renewal fee patent year 09
16.09.2024Renewal fee patent year 10
16.09.2024Renewal fee patent year 11
16.09.2024Renewal fee patent year 12
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[YD]WO03002136  (NOVO NORDISK AS [DK]);
 [YD]WO2006097537  (NOVO NORDISK AS [DK], et al);
 [Y]WO2011138421  (BOEHRINGER INGELHEIM INT [DE], et al);
by applicantWO9319175
 WO9808871
 WO03002136
 WO2005027978
 WO2005049061
 WO2006097537
 WO2008145728
 WO2009030738
 WO2009083549
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.